Showing results (751-760 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|September 14, 2023
A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosisShivani Chiranth, Seppo W Langer, Hans Skovgaard Poulsen, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Neuro-Oncology Advances|August 28, 2023
Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastomaTejpal Gupta, Jeevi Mona Priyadharshni Selvarajan, Sadhana Kannan, et al.
Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.
Neuro-Oncology Advances|August 7, 2023
Investigation of neurophysiologic and functional connectivity changes following glioma resection using magnetoencephalographyNardin Samuel, Irene E Harmsen, Mandy Yi Rong Ding, et al.
Neuro-Oncology Advances|October 27, 2023
The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtypeMaria Fala, Susana Ros, Ashley Sawle, et al.
Neuro-Oncology Advances|October 16, 2023
The value of arterial spin labelling (ASL) perfusion MRI in the assessment of post-treatment progression in adult glioma: A systematic review and meta-analysisTamadur A Alsulami, Harpreet Hyare, David L Thomas, et al.
Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.
Neuro-Oncology Advances|October 9, 2023
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022Christoph Oster, Teresa Schmidt, Sarina Agkatsev, et al.
Neuro-Oncology Advances|October 23, 2023
Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort studyLine Sagerup Bjorland, Rupavathana Mahesparan, Øystein Fluge, et al.
Pageof 138